Interview: Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments

IGTV’s Jeremy Naylor caught up with Stephen O’Hara, a microbiologist who has become a prolific biotech entrepreneur. This latest business is growing fast, and he explains how he sees this year developing for the company.

Probiotic Disease Cardiovascular disease

Written by: Jeremy Naylor | Analyst, London

Publication date: 2023-02-24T01:39:05+0000

As cardiovascular disease and other lifestyle conditions affect growing numbers of people across the world, demand for supplements increases. ProBiotix Health Plc has become a global leader in microbiome modulating probiotics for use in functional foods, supplements and biotherapeutics.

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Explore the markets with our free course

Try IG Academy

Put learning into action

Try out what you’ve learned in this shares strategy article risk-free in your demo account.

Try it out

Ready to trade shares?

Put the lessons in this article to use in a live account – upgrading is quick and easy.

Trade over 12 000 popular global stocks
Protect your capital with risk management tools
React to breaking news with out-of-hours trading on 70 key US stocks

Create live account

Inspired to trade?

Put your new knowledge into practice. Log in to your account now.

Live prices on most popular markets

Forex
Shares
Indices

See more forex live prices

See more shares live prices

See more indices live prices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

<h3>How much does trading cost?</h3>

<h3>Find out about IG</h3>

<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

This website is owned and operated by IG Bank S.A. Registered address at 42 Rue du Rhone, 1204 Geneva, authorised and regulated by FINMA.

The information on this site is not directed at residents of the United States and Belgium, or any particular country outside Switzerland and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

TOP PARTNER